Global Companion Diagnostic Tests Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Companion Diagnostic Tests market size was valued at US$ million in 2023. With growing demand in downstream market, the Companion Diagnostic Tests is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Companion Diagnostic Tests market. Companion Diagnostic Tests are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Companion Diagnostic Tests. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Companion Diagnostic Tests market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Companion Diagnostic Tests market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Companion Diagnostic Tests market. It may include historical data, market segmentation by Type (e.g., Protein Detection, DNA Detection), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Companion Diagnostic Tests market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Companion Diagnostic Tests market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Companion Diagnostic Tests industry. This include advancements in Companion Diagnostic Tests technology, Companion Diagnostic Tests new entrants, Companion Diagnostic Tests new investment, and other innovations that are shaping the future of Companion Diagnostic Tests.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Companion Diagnostic Tests market. It includes factors influencing customer ' purchasing decisions, preferences for Companion Diagnostic Tests product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Companion Diagnostic Tests market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Companion Diagnostic Tests market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Companion Diagnostic Tests market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Companion Diagnostic Tests industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Companion Diagnostic Tests market.
Market Segmentation:
Companion Diagnostic Tests market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Companion Diagnostic Tests market size was valued at US$ million in 2023. With growing demand in downstream market, the Companion Diagnostic Tests is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Companion Diagnostic Tests market. Companion Diagnostic Tests are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Companion Diagnostic Tests. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Companion Diagnostic Tests market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Companion Diagnostic Tests market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Companion Diagnostic Tests market. It may include historical data, market segmentation by Type (e.g., Protein Detection, DNA Detection), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Companion Diagnostic Tests market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Companion Diagnostic Tests market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Companion Diagnostic Tests industry. This include advancements in Companion Diagnostic Tests technology, Companion Diagnostic Tests new entrants, Companion Diagnostic Tests new investment, and other innovations that are shaping the future of Companion Diagnostic Tests.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Companion Diagnostic Tests market. It includes factors influencing customer ' purchasing decisions, preferences for Companion Diagnostic Tests product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Companion Diagnostic Tests market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Companion Diagnostic Tests market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Companion Diagnostic Tests market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Companion Diagnostic Tests industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Companion Diagnostic Tests market.
Market Segmentation:
Companion Diagnostic Tests market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Protein Detection
- DNA Detection
- Hybridization
- Biomarker
- Others
- Pharmaceutical and Biotechnology Companies
- Medical Device Companies
- Research Institutes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- F. Hoffman LA Roche Ltd.
- QIAGEN, Illumina, Inc.
- Abbott
- Agilent Technologies, Inc.
- Genomic Health, Inc.
- BioMerieux SA, BioGenex
- AGENDIA NV
- Siemens Healthcare GmBH
- Thermo Fisher Scientific, Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Companion Diagnostic Tests Market Size 2019-2030
2.1.2 Companion Diagnostic Tests Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Companion Diagnostic Tests Segment by Type
2.2.1 Protein Detection
2.2.2 DNA Detection
2.2.3 Hybridization
2.2.4 Biomarker
2.2.5 Others
2.3 Companion Diagnostic Tests Market Size by Type
2.3.1 Companion Diagnostic Tests Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
2.4 Companion Diagnostic Tests Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 Medical Device Companies
2.4.3 Research Institutes
2.5 Companion Diagnostic Tests Market Size by Application
2.5.1 Companion Diagnostic Tests Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Companion Diagnostic Tests Market Size Market Share by Application (2019-2024)
3 COMPANION DIAGNOSTIC TESTS MARKET SIZE BY PLAYER
3.1 Companion Diagnostic Tests Market Size Market Share by Players
3.1.1 Global Companion Diagnostic Tests Revenue by Players (2019-2024)
3.1.2 Global Companion Diagnostic Tests Revenue Market Share by Players (2019-2024)
3.2 Global Companion Diagnostic Tests Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTIC TESTS BY REGIONS
4.1 Companion Diagnostic Tests Market Size by Regions (2019-2024)
4.2 Americas Companion Diagnostic Tests Market Size Growth (2019-2024)
4.3 APAC Companion Diagnostic Tests Market Size Growth (2019-2024)
4.4 Europe Companion Diagnostic Tests Market Size Growth (2019-2024)
4.5 Middle East & Africa Companion Diagnostic Tests Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Companion Diagnostic Tests Market Size by Country (2019-2024)
5.2 Americas Companion Diagnostic Tests Market Size by Type (2019-2024)
5.3 Americas Companion Diagnostic Tests Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Companion Diagnostic Tests Market Size by Region (2019-2024)
6.2 APAC Companion Diagnostic Tests Market Size by Type (2019-2024)
6.3 APAC Companion Diagnostic Tests Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Companion Diagnostic Tests by Country (2019-2024)
7.2 Europe Companion Diagnostic Tests Market Size by Type (2019-2024)
7.3 Europe Companion Diagnostic Tests Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Companion Diagnostic Tests by Region (2019-2024)
8.2 Middle East & Africa Companion Diagnostic Tests Market Size by Type (2019-2024)
8.3 Middle East & Africa Companion Diagnostic Tests Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL COMPANION DIAGNOSTIC TESTS MARKET FORECAST
10.1 Global Companion Diagnostic Tests Forecast by Regions (2025-2030)
10.1.1 Global Companion Diagnostic Tests Forecast by Regions (2025-2030)
10.1.2 Americas Companion Diagnostic Tests Forecast
10.1.3 APAC Companion Diagnostic Tests Forecast
10.1.4 Europe Companion Diagnostic Tests Forecast
10.1.5 Middle East & Africa Companion Diagnostic Tests Forecast
10.2 Americas Companion Diagnostic Tests Forecast by Country (2025-2030)
10.2.1 United States Companion Diagnostic Tests Market Forecast
10.2.2 Canada Companion Diagnostic Tests Market Forecast
10.2.3 Mexico Companion Diagnostic Tests Market Forecast
10.2.4 Brazil Companion Diagnostic Tests Market Forecast
10.3 APAC Companion Diagnostic Tests Forecast by Region (2025-2030)
10.3.1 China Companion Diagnostic Tests Market Forecast
10.3.2 Japan Companion Diagnostic Tests Market Forecast
10.3.3 Korea Companion Diagnostic Tests Market Forecast
10.3.4 Southeast Asia Companion Diagnostic Tests Market Forecast
10.3.5 India Companion Diagnostic Tests Market Forecast
10.3.6 Australia Companion Diagnostic Tests Market Forecast
10.4 Europe Companion Diagnostic Tests Forecast by Country (2025-2030)
10.4.1 Germany Companion Diagnostic Tests Market Forecast
10.4.2 France Companion Diagnostic Tests Market Forecast
10.4.3 UK Companion Diagnostic Tests Market Forecast
10.4.4 Italy Companion Diagnostic Tests Market Forecast
10.4.5 Russia Companion Diagnostic Tests Market Forecast
10.5 Middle East & Africa Companion Diagnostic Tests Forecast by Region (2025-2030)
10.5.1 Egypt Companion Diagnostic Tests Market Forecast
10.5.2 South Africa Companion Diagnostic Tests Market Forecast
10.5.3 Israel Companion Diagnostic Tests Market Forecast
10.5.4 Turkey Companion Diagnostic Tests Market Forecast
10.5.5 GCC Countries Companion Diagnostic Tests Market Forecast
10.6 Global Companion Diagnostic Tests Forecast by Type (2025-2030)
10.7 Global Companion Diagnostic Tests Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 F. Hoffman LA Roche Ltd.
11.1.1 F. Hoffman LA Roche Ltd. Company Information
11.1.2 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Product Offered
11.1.3 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 F. Hoffman LA Roche Ltd. Main Business Overview
11.1.5 F. Hoffman LA Roche Ltd. Latest Developments
11.2 QIAGEN, Illumina, Inc.
11.2.1 QIAGEN, Illumina, Inc. Company Information
11.2.2 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Product Offered
11.2.3 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 QIAGEN, Illumina, Inc. Main Business Overview
11.2.5 QIAGEN, Illumina, Inc. Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Companion Diagnostic Tests Product Offered
11.3.3 Abbott Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 Agilent Technologies, Inc.
11.4.1 Agilent Technologies, Inc. Company Information
11.4.2 Agilent Technologies, Inc. Companion Diagnostic Tests Product Offered
11.4.3 Agilent Technologies, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Agilent Technologies, Inc. Main Business Overview
11.4.5 Agilent Technologies, Inc. Latest Developments
11.5 Genomic Health, Inc.
11.5.1 Genomic Health, Inc. Company Information
11.5.2 Genomic Health, Inc. Companion Diagnostic Tests Product Offered
11.5.3 Genomic Health, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Genomic Health, Inc. Main Business Overview
11.5.5 Genomic Health, Inc. Latest Developments
11.6 BioMerieux SA, BioGenex
11.6.1 BioMerieux SA, BioGenex Company Information
11.6.2 BioMerieux SA, BioGenex Companion Diagnostic Tests Product Offered
11.6.3 BioMerieux SA, BioGenex Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 BioMerieux SA, BioGenex Main Business Overview
11.6.5 BioMerieux SA, BioGenex Latest Developments
11.7 AGENDIA NV
11.7.1 AGENDIA NV Company Information
11.7.2 AGENDIA NV Companion Diagnostic Tests Product Offered
11.7.3 AGENDIA NV Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 AGENDIA NV Main Business Overview
11.7.5 AGENDIA NV Latest Developments
11.8 Siemens Healthcare GmBH
11.8.1 Siemens Healthcare GmBH Company Information
11.8.2 Siemens Healthcare GmBH Companion Diagnostic Tests Product Offered
11.8.3 Siemens Healthcare GmBH Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Siemens Healthcare GmBH Main Business Overview
11.8.5 Siemens Healthcare GmBH Latest Developments
11.9 Thermo Fisher Scientific, Inc.
11.9.1 Thermo Fisher Scientific, Inc. Company Information
11.9.2 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Product Offered
11.9.3 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.9.5 Thermo Fisher Scientific, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Companion Diagnostic Tests Market Size 2019-2030
2.1.2 Companion Diagnostic Tests Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Companion Diagnostic Tests Segment by Type
2.2.1 Protein Detection
2.2.2 DNA Detection
2.2.3 Hybridization
2.2.4 Biomarker
2.2.5 Others
2.3 Companion Diagnostic Tests Market Size by Type
2.3.1 Companion Diagnostic Tests Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
2.4 Companion Diagnostic Tests Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 Medical Device Companies
2.4.3 Research Institutes
2.5 Companion Diagnostic Tests Market Size by Application
2.5.1 Companion Diagnostic Tests Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Companion Diagnostic Tests Market Size Market Share by Application (2019-2024)
3 COMPANION DIAGNOSTIC TESTS MARKET SIZE BY PLAYER
3.1 Companion Diagnostic Tests Market Size Market Share by Players
3.1.1 Global Companion Diagnostic Tests Revenue by Players (2019-2024)
3.1.2 Global Companion Diagnostic Tests Revenue Market Share by Players (2019-2024)
3.2 Global Companion Diagnostic Tests Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTIC TESTS BY REGIONS
4.1 Companion Diagnostic Tests Market Size by Regions (2019-2024)
4.2 Americas Companion Diagnostic Tests Market Size Growth (2019-2024)
4.3 APAC Companion Diagnostic Tests Market Size Growth (2019-2024)
4.4 Europe Companion Diagnostic Tests Market Size Growth (2019-2024)
4.5 Middle East & Africa Companion Diagnostic Tests Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Companion Diagnostic Tests Market Size by Country (2019-2024)
5.2 Americas Companion Diagnostic Tests Market Size by Type (2019-2024)
5.3 Americas Companion Diagnostic Tests Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Companion Diagnostic Tests Market Size by Region (2019-2024)
6.2 APAC Companion Diagnostic Tests Market Size by Type (2019-2024)
6.3 APAC Companion Diagnostic Tests Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Companion Diagnostic Tests by Country (2019-2024)
7.2 Europe Companion Diagnostic Tests Market Size by Type (2019-2024)
7.3 Europe Companion Diagnostic Tests Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Companion Diagnostic Tests by Region (2019-2024)
8.2 Middle East & Africa Companion Diagnostic Tests Market Size by Type (2019-2024)
8.3 Middle East & Africa Companion Diagnostic Tests Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL COMPANION DIAGNOSTIC TESTS MARKET FORECAST
10.1 Global Companion Diagnostic Tests Forecast by Regions (2025-2030)
10.1.1 Global Companion Diagnostic Tests Forecast by Regions (2025-2030)
10.1.2 Americas Companion Diagnostic Tests Forecast
10.1.3 APAC Companion Diagnostic Tests Forecast
10.1.4 Europe Companion Diagnostic Tests Forecast
10.1.5 Middle East & Africa Companion Diagnostic Tests Forecast
10.2 Americas Companion Diagnostic Tests Forecast by Country (2025-2030)
10.2.1 United States Companion Diagnostic Tests Market Forecast
10.2.2 Canada Companion Diagnostic Tests Market Forecast
10.2.3 Mexico Companion Diagnostic Tests Market Forecast
10.2.4 Brazil Companion Diagnostic Tests Market Forecast
10.3 APAC Companion Diagnostic Tests Forecast by Region (2025-2030)
10.3.1 China Companion Diagnostic Tests Market Forecast
10.3.2 Japan Companion Diagnostic Tests Market Forecast
10.3.3 Korea Companion Diagnostic Tests Market Forecast
10.3.4 Southeast Asia Companion Diagnostic Tests Market Forecast
10.3.5 India Companion Diagnostic Tests Market Forecast
10.3.6 Australia Companion Diagnostic Tests Market Forecast
10.4 Europe Companion Diagnostic Tests Forecast by Country (2025-2030)
10.4.1 Germany Companion Diagnostic Tests Market Forecast
10.4.2 France Companion Diagnostic Tests Market Forecast
10.4.3 UK Companion Diagnostic Tests Market Forecast
10.4.4 Italy Companion Diagnostic Tests Market Forecast
10.4.5 Russia Companion Diagnostic Tests Market Forecast
10.5 Middle East & Africa Companion Diagnostic Tests Forecast by Region (2025-2030)
10.5.1 Egypt Companion Diagnostic Tests Market Forecast
10.5.2 South Africa Companion Diagnostic Tests Market Forecast
10.5.3 Israel Companion Diagnostic Tests Market Forecast
10.5.4 Turkey Companion Diagnostic Tests Market Forecast
10.5.5 GCC Countries Companion Diagnostic Tests Market Forecast
10.6 Global Companion Diagnostic Tests Forecast by Type (2025-2030)
10.7 Global Companion Diagnostic Tests Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 F. Hoffman LA Roche Ltd.
11.1.1 F. Hoffman LA Roche Ltd. Company Information
11.1.2 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Product Offered
11.1.3 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 F. Hoffman LA Roche Ltd. Main Business Overview
11.1.5 F. Hoffman LA Roche Ltd. Latest Developments
11.2 QIAGEN, Illumina, Inc.
11.2.1 QIAGEN, Illumina, Inc. Company Information
11.2.2 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Product Offered
11.2.3 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 QIAGEN, Illumina, Inc. Main Business Overview
11.2.5 QIAGEN, Illumina, Inc. Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Companion Diagnostic Tests Product Offered
11.3.3 Abbott Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 Agilent Technologies, Inc.
11.4.1 Agilent Technologies, Inc. Company Information
11.4.2 Agilent Technologies, Inc. Companion Diagnostic Tests Product Offered
11.4.3 Agilent Technologies, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Agilent Technologies, Inc. Main Business Overview
11.4.5 Agilent Technologies, Inc. Latest Developments
11.5 Genomic Health, Inc.
11.5.1 Genomic Health, Inc. Company Information
11.5.2 Genomic Health, Inc. Companion Diagnostic Tests Product Offered
11.5.3 Genomic Health, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Genomic Health, Inc. Main Business Overview
11.5.5 Genomic Health, Inc. Latest Developments
11.6 BioMerieux SA, BioGenex
11.6.1 BioMerieux SA, BioGenex Company Information
11.6.2 BioMerieux SA, BioGenex Companion Diagnostic Tests Product Offered
11.6.3 BioMerieux SA, BioGenex Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 BioMerieux SA, BioGenex Main Business Overview
11.6.5 BioMerieux SA, BioGenex Latest Developments
11.7 AGENDIA NV
11.7.1 AGENDIA NV Company Information
11.7.2 AGENDIA NV Companion Diagnostic Tests Product Offered
11.7.3 AGENDIA NV Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 AGENDIA NV Main Business Overview
11.7.5 AGENDIA NV Latest Developments
11.8 Siemens Healthcare GmBH
11.8.1 Siemens Healthcare GmBH Company Information
11.8.2 Siemens Healthcare GmBH Companion Diagnostic Tests Product Offered
11.8.3 Siemens Healthcare GmBH Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Siemens Healthcare GmBH Main Business Overview
11.8.5 Siemens Healthcare GmBH Latest Developments
11.9 Thermo Fisher Scientific, Inc.
11.9.1 Thermo Fisher Scientific, Inc. Company Information
11.9.2 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Product Offered
11.9.3 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.9.5 Thermo Fisher Scientific, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
.
Table 1. Companion Diagnostic Tests Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Protein Detection
Table 3. Major Players of DNA Detection
Table 4. Major Players of Hybridization
Table 5. Major Players of Biomarker
Table 6. Major Players of Others
Table 7. Companion Diagnostic Tests Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Companion Diagnostic Tests Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
Table 10. Companion Diagnostic Tests Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Companion Diagnostic Tests Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Companion Diagnostic Tests Market Size Market Share by Application (2019-2024)
Table 13. Global Companion Diagnostic Tests Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Companion Diagnostic Tests Revenue Market Share by Player (2019-2024)
Table 15. Companion Diagnostic Tests Key Players Head office and Products Offered
Table 16. Companion Diagnostic Tests Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Companion Diagnostic Tests Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Companion Diagnostic Tests Market Size Market Share by Regions (2019-2024)
Table 21. Global Companion Diagnostic Tests Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Companion Diagnostic Tests Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Companion Diagnostic Tests Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Companion Diagnostic Tests Market Size Market Share by Country (2019-2024)
Table 25. Americas Companion Diagnostic Tests Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
Table 27. Americas Companion Diagnostic Tests Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Companion Diagnostic Tests Market Size Market Share by Application (2019-2024)
Table 29. APAC Companion Diagnostic Tests Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Companion Diagnostic Tests Market Size Market Share by Region (2019-2024)
Table 31. APAC Companion Diagnostic Tests Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
Table 33. APAC Companion Diagnostic Tests Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Companion Diagnostic Tests Market Size Market Share by Application (2019-2024)
Table 35. Europe Companion Diagnostic Tests Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Companion Diagnostic Tests Market Size Market Share by Country (2019-2024)
Table 37. Europe Companion Diagnostic Tests Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
Table 39. Europe Companion Diagnostic Tests Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Companion Diagnostic Tests Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Companion Diagnostic Tests Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Companion Diagnostic Tests Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Companion Diagnostic Tests Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Companion Diagnostic Tests
Table 48. Key Market Challenges & Risks of Companion Diagnostic Tests
Table 49. Key Industry Trends of Companion Diagnostic Tests
Table 50. Global Companion Diagnostic Tests Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Companion Diagnostic Tests Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Companion Diagnostic Tests Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Companion Diagnostic Tests Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. F. Hoffman LA Roche Ltd. Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 55. F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Product Offered
Table 56. F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. F. Hoffman LA Roche Ltd. Main Business
Table 58. F. Hoffman LA Roche Ltd. Latest Developments
Table 59. QIAGEN, Illumina, Inc. Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 60. QIAGEN, Illumina, Inc. Companion Diagnostic Tests Product Offered
Table 61. QIAGEN, Illumina, Inc. Main Business
Table 62. QIAGEN, Illumina, Inc. Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. QIAGEN, Illumina, Inc. Latest Developments
Table 64. Abbott Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 65. Abbott Companion Diagnostic Tests Product Offered
Table 66. Abbott Main Business
Table 67. Abbott Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Abbott Latest Developments
Table 69. Agilent Technologies, Inc. Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 70. Agilent Technologies, Inc. Companion Diagnostic Tests Product Offered
Table 71. Agilent Technologies, Inc. Main Business
Table 72. Agilent Technologies, Inc. Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Agilent Technologies, Inc. Latest Developments
Table 74. Genomic Health, Inc. Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 75. Genomic Health, Inc. Companion Diagnostic Tests Product Offered
Table 76. Genomic Health, Inc. Main Business
Table 77. Genomic Health, Inc. Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Genomic Health, Inc. Latest Developments
Table 79. BioMerieux SA, BioGenex Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 80. BioMerieux SA, BioGenex Companion Diagnostic Tests Product Offered
Table 81. BioMerieux SA, BioGenex Main Business
Table 82. BioMerieux SA, BioGenex Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. BioMerieux SA, BioGenex Latest Developments
Table 84. AGENDIA NV Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 85. AGENDIA NV Companion Diagnostic Tests Product Offered
Table 86. AGENDIA NV Main Business
Table 87. AGENDIA NV Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. AGENDIA NV Latest Developments
Table 89. Siemens Healthcare GmBH Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 90. Siemens Healthcare GmBH Companion Diagnostic Tests Product Offered
Table 91. Siemens Healthcare GmBH Main Business
Table 92. Siemens Healthcare GmBH Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Siemens Healthcare GmBH Latest Developments
Table 94. Thermo Fisher Scientific, Inc. Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 95. Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Product Offered
Table 96. Thermo Fisher Scientific, Inc. Main Business
Table 97. Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Thermo Fisher Scientific, Inc. Latest Developments
.
Table 1. Companion Diagnostic Tests Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Protein Detection
Table 3. Major Players of DNA Detection
Table 4. Major Players of Hybridization
Table 5. Major Players of Biomarker
Table 6. Major Players of Others
Table 7. Companion Diagnostic Tests Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Companion Diagnostic Tests Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
Table 10. Companion Diagnostic Tests Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Companion Diagnostic Tests Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Companion Diagnostic Tests Market Size Market Share by Application (2019-2024)
Table 13. Global Companion Diagnostic Tests Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Companion Diagnostic Tests Revenue Market Share by Player (2019-2024)
Table 15. Companion Diagnostic Tests Key Players Head office and Products Offered
Table 16. Companion Diagnostic Tests Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Companion Diagnostic Tests Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Companion Diagnostic Tests Market Size Market Share by Regions (2019-2024)
Table 21. Global Companion Diagnostic Tests Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Companion Diagnostic Tests Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Companion Diagnostic Tests Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Companion Diagnostic Tests Market Size Market Share by Country (2019-2024)
Table 25. Americas Companion Diagnostic Tests Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
Table 27. Americas Companion Diagnostic Tests Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Companion Diagnostic Tests Market Size Market Share by Application (2019-2024)
Table 29. APAC Companion Diagnostic Tests Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Companion Diagnostic Tests Market Size Market Share by Region (2019-2024)
Table 31. APAC Companion Diagnostic Tests Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
Table 33. APAC Companion Diagnostic Tests Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Companion Diagnostic Tests Market Size Market Share by Application (2019-2024)
Table 35. Europe Companion Diagnostic Tests Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Companion Diagnostic Tests Market Size Market Share by Country (2019-2024)
Table 37. Europe Companion Diagnostic Tests Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
Table 39. Europe Companion Diagnostic Tests Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Companion Diagnostic Tests Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Companion Diagnostic Tests Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Companion Diagnostic Tests Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Companion Diagnostic Tests Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Companion Diagnostic Tests
Table 48. Key Market Challenges & Risks of Companion Diagnostic Tests
Table 49. Key Industry Trends of Companion Diagnostic Tests
Table 50. Global Companion Diagnostic Tests Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Companion Diagnostic Tests Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Companion Diagnostic Tests Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Companion Diagnostic Tests Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. F. Hoffman LA Roche Ltd. Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 55. F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Product Offered
Table 56. F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. F. Hoffman LA Roche Ltd. Main Business
Table 58. F. Hoffman LA Roche Ltd. Latest Developments
Table 59. QIAGEN, Illumina, Inc. Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 60. QIAGEN, Illumina, Inc. Companion Diagnostic Tests Product Offered
Table 61. QIAGEN, Illumina, Inc. Main Business
Table 62. QIAGEN, Illumina, Inc. Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. QIAGEN, Illumina, Inc. Latest Developments
Table 64. Abbott Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 65. Abbott Companion Diagnostic Tests Product Offered
Table 66. Abbott Main Business
Table 67. Abbott Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Abbott Latest Developments
Table 69. Agilent Technologies, Inc. Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 70. Agilent Technologies, Inc. Companion Diagnostic Tests Product Offered
Table 71. Agilent Technologies, Inc. Main Business
Table 72. Agilent Technologies, Inc. Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Agilent Technologies, Inc. Latest Developments
Table 74. Genomic Health, Inc. Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 75. Genomic Health, Inc. Companion Diagnostic Tests Product Offered
Table 76. Genomic Health, Inc. Main Business
Table 77. Genomic Health, Inc. Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Genomic Health, Inc. Latest Developments
Table 79. BioMerieux SA, BioGenex Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 80. BioMerieux SA, BioGenex Companion Diagnostic Tests Product Offered
Table 81. BioMerieux SA, BioGenex Main Business
Table 82. BioMerieux SA, BioGenex Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. BioMerieux SA, BioGenex Latest Developments
Table 84. AGENDIA NV Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 85. AGENDIA NV Companion Diagnostic Tests Product Offered
Table 86. AGENDIA NV Main Business
Table 87. AGENDIA NV Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. AGENDIA NV Latest Developments
Table 89. Siemens Healthcare GmBH Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 90. Siemens Healthcare GmBH Companion Diagnostic Tests Product Offered
Table 91. Siemens Healthcare GmBH Main Business
Table 92. Siemens Healthcare GmBH Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Siemens Healthcare GmBH Latest Developments
Table 94. Thermo Fisher Scientific, Inc. Details, Company Type, Companion Diagnostic Tests Area Served and Its Competitors
Table 95. Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Product Offered
Table 96. Thermo Fisher Scientific, Inc. Main Business
Table 97. Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Thermo Fisher Scientific, Inc. Latest Developments
LIST OF FIGURES
.
Figure 1. Companion Diagnostic Tests Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Companion Diagnostic Tests Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Companion Diagnostic Tests Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Companion Diagnostic Tests Sales Market Share by Country/Region (2023)
Figure 8. Companion Diagnostic Tests Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Companion Diagnostic Tests Market Size Market Share by Type in 2023
Figure 10. Companion Diagnostic Tests in Pharmaceutical and Biotechnology Companies
Figure 11. Global Companion Diagnostic Tests Market: Pharmaceutical and Biotechnology Companies (2019-2024) & ($ Millions)
Figure 12. Companion Diagnostic Tests in Medical Device Companies
Figure 13. Global Companion Diagnostic Tests Market: Medical Device Companies (2019-2024) & ($ Millions)
Figure 14. Companion Diagnostic Tests in Research Institutes
Figure 15. Global Companion Diagnostic Tests Market: Research Institutes (2019-2024) & ($ Millions)
Figure 16. Global Companion Diagnostic Tests Market Size Market Share by Application in 2023
Figure 17. Global Companion Diagnostic Tests Revenue Market Share by Player in 2023
Figure 18. Global Companion Diagnostic Tests Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Companion Diagnostic Tests Market Size 2019-2024 ($ Millions)
Figure 20. APAC Companion Diagnostic Tests Market Size 2019-2024 ($ Millions)
Figure 21. Europe Companion Diagnostic Tests Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Companion Diagnostic Tests Market Size 2019-2024 ($ Millions)
Figure 23. Americas Companion Diagnostic Tests Value Market Share by Country in 2023
Figure 24. United States Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Companion Diagnostic Tests Market Size Market Share by Region in 2023
Figure 29. APAC Companion Diagnostic Tests Market Size Market Share by Type in 2023
Figure 30. APAC Companion Diagnostic Tests Market Size Market Share by Application in 2023
Figure 31. China Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Companion Diagnostic Tests Market Size Market Share by Country in 2023
Figure 38. Europe Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
Figure 39. Europe Companion Diagnostic Tests Market Size Market Share by Application (2019-2024)
Figure 40. Germany Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 54. APAC Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 55. Europe Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 57. United States Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 58. Canada Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 61. China Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 62. Japan Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 63. Korea Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 65. India Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 66. Australia Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 67. Germany Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 68. France Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 69. UK Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 70. Italy Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 71. Russia Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 72. Spain Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 75. Israel Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 78. Global Companion Diagnostic Tests Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Companion Diagnostic Tests Market Size Market Share Forecast by Application (2025-2030)
.
Figure 1. Companion Diagnostic Tests Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Companion Diagnostic Tests Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Companion Diagnostic Tests Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Companion Diagnostic Tests Sales Market Share by Country/Region (2023)
Figure 8. Companion Diagnostic Tests Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Companion Diagnostic Tests Market Size Market Share by Type in 2023
Figure 10. Companion Diagnostic Tests in Pharmaceutical and Biotechnology Companies
Figure 11. Global Companion Diagnostic Tests Market: Pharmaceutical and Biotechnology Companies (2019-2024) & ($ Millions)
Figure 12. Companion Diagnostic Tests in Medical Device Companies
Figure 13. Global Companion Diagnostic Tests Market: Medical Device Companies (2019-2024) & ($ Millions)
Figure 14. Companion Diagnostic Tests in Research Institutes
Figure 15. Global Companion Diagnostic Tests Market: Research Institutes (2019-2024) & ($ Millions)
Figure 16. Global Companion Diagnostic Tests Market Size Market Share by Application in 2023
Figure 17. Global Companion Diagnostic Tests Revenue Market Share by Player in 2023
Figure 18. Global Companion Diagnostic Tests Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Companion Diagnostic Tests Market Size 2019-2024 ($ Millions)
Figure 20. APAC Companion Diagnostic Tests Market Size 2019-2024 ($ Millions)
Figure 21. Europe Companion Diagnostic Tests Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Companion Diagnostic Tests Market Size 2019-2024 ($ Millions)
Figure 23. Americas Companion Diagnostic Tests Value Market Share by Country in 2023
Figure 24. United States Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Companion Diagnostic Tests Market Size Market Share by Region in 2023
Figure 29. APAC Companion Diagnostic Tests Market Size Market Share by Type in 2023
Figure 30. APAC Companion Diagnostic Tests Market Size Market Share by Application in 2023
Figure 31. China Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Companion Diagnostic Tests Market Size Market Share by Country in 2023
Figure 38. Europe Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
Figure 39. Europe Companion Diagnostic Tests Market Size Market Share by Application (2019-2024)
Figure 40. Germany Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Companion Diagnostic Tests Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 54. APAC Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 55. Europe Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 57. United States Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 58. Canada Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 61. China Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 62. Japan Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 63. Korea Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 65. India Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 66. Australia Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 67. Germany Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 68. France Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 69. UK Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 70. Italy Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 71. Russia Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 72. Spain Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 75. Israel Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Companion Diagnostic Tests Market Size 2025-2030 ($ Millions)
Figure 78. Global Companion Diagnostic Tests Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Companion Diagnostic Tests Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Medical Electronic Humidifier Market Growth 2023-2029
US$ 3,660.00
February 2023
108 pages
Global Microneedle Drug Delivery Systems Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
January 2025
115 pages
Global Emergency Stretcher Market Growth 2025-2031
US$ 3,660.00
December 2024
145 pages
Global Adenosine Deaminase Deficiency Drugs Market Growth 2024-2030
US$ 3,660.00
March 2024
82 pages
Global Intra Oral Scanners For Digital Impression Market Growth 2025-2031
US$ 3,660.00
May 2025
116 pages
